NEW YORK CITY — IBM Watson Health (NYSE: IBfM) today announced that it is collaborating with more than a dozen leading cancer institutes to accelerate the ability of clinicians to identify and personalize treatment options for their patients. The institutes will apply Watson’s advanced cognitive capabilities to reduce from weeks to minutes the ability to […]
SANTA CLARA, Calif., and BOSTON — Agilent Technologies Inc. (NYSE: A) and Cartagenia today announced that they have signed a definitive agreement under which Agilent will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia, which has offices in Leuven, Belgium, and Boston, Massachusetts, provides software solutions […]
Shenzhen, China, and Redwood City, California -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that it has expanded its relationship with BGI, the world’s largest genomics organization, to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing […]
GOLDEN, Colo. — Waters Corporation (NYSE:WAT) today announced that ERA®, A Waters® Business, introduced the new eDATA® 2.0 Proficiency Testing (PT) portal enabling environmental laboratories to manage their proficiency testing data more efficiently and gain greater insight into their laboratory’s performance. The portal features new statistical analysis, data visualization and reporting tools that give environmental […]
Cambridge, MA & Budapest, Hungary -– Biodata, producer of Labguru, the only web-based electronic lab notebook with integrated protocols and specimen management systems, and ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, announce their collaboration that led to the development of Labguru’s newest feature: chemical structure and reaction […]
LANCASTER, Calif. — Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that Michael Lawless, Ph.D., will transition to the Marketing and Sales team as Business Development Manager, Cheminformatics Solutions. In addition, the company announced the appointment of Vijay K. Gombar, Ph.D., to the […]
SAN DIEGO –– Finding genetic causes of progressive supranuclear palsy (PSP) is the goal of a joint research project announced today between Cypher Genomics and the University of Pennsylvania. The research is funded by a grant from CurePSP. PSP is a neurodegenerative brain disease that affects nerve cells that control walking, balance, mobility, vision, speech, […]
LANCASTER, Calif. — Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has released the long-awaited Version 9.0 of its flagship GastroPlus™ simulation software. Dr. Michael Bolger, chief scientist of Simulations Plus, said: “We’re very pleased to announce the release of GastroPlus […]
LANCASTER, Calif. — Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that Michael Lawless, Ph.D., will transition to the Marketing and Sales team as Business Development Manager, Cheminformatics Solutions. In addition, the company announced the appointment of Vijay K. Gombar, Ph.D., to the […]
Wilmington, DE — The Pistoia Alliance, a global, not-for-profit alliance of life science organizations that work together to lower barriers to innovation in R&D, has announced the start of its new Ontologies Mapping project. The Ontologies Mapping project has been set up to create better tools and establish best practices for ontology management in life […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
